NCT06088407View on ClinicalTrials.gov

Tranexamic Acid Prophylaxis for Heterotopic Ossification in Elbow Fracture-Dislocation Surgery

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 21, 2016

Primary Completion Date

September 3, 2023

Study Completion Date

September 3, 2023

Conditions
Elbow DislocationHeterotopic Ossification
Interventions
DRUG

with Tranexamic acid

Patients undergoing surgery for elbow fracture-dislocation randomized to be treated with tranexamic acid intravenous intraoperatively

Trial Locations (1)

70300

Assaf Harofeh Medical Center (Yitzhak Shamir Medical Center), Be’er Ya‘aqov

All Listed Sponsors
lead

Assaf-Harofeh Medical Center

OTHER_GOV

NCT06088407 - Tranexamic Acid Prophylaxis for Heterotopic Ossification in Elbow Fracture-Dislocation Surgery | Biotech Hunter | Biotech Hunter